An immunotherapy treatment is set to be made available to more patients with acute lymphoblastic leukaemia (ALL) in England as a second line therapy, it has been announced.
Blinatumomab has gained approval for use in the NHS in England ten years a...
4 months ago
British researchers have launched a major trial to see if a concentrated form of pooled plasma will improve outcomes for patients suffering bleeding after heart surgery.
The project, known as Prophesy-2, will directly compare Prothrombin Complex C...
4 months ago
